Cargando…
Safety of indacaterol in the treatment of patients with COPD
PURPOSE: Pooled data were analyzed to evaluate the safety and tolerability of indacaterol, a once-daily inhaled long-acting β(2)-agonist for chronic obstructive pulmonary disease (COPD). PATIENTS AND METHODS: Data were pooled from clinical studies of 3–12 months’ duration in patients with moderate-t...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186746/ https://www.ncbi.nlm.nih.gov/pubmed/22003293 http://dx.doi.org/10.2147/COPD.S23816 |